Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Global Sciences is a cannabinoid-focused consumer products and distribution company that has marketed hemp-derived CBD products including tinctures, hydration beverages, topicals, vaporizers, sublingual tablets, gel caps, and transdermal patches. Historically, the company described itself as vertically integrated across hemp cultivation, extraction, product development, manufacturing, and distribution. Public disclosures and exchange materials indicate that the business later broadened beyond CBD into brand incubation, beverage and snack distribution, and manufacturing through subsidiaries such as Legacy Distribution Group and Resinosa. The company was publicly listed in Canada under the symbol CBDN and traded in the U.S. as CBDNF, and it has also been referred to as Global Sciences and later Illumination Brands. For a biotech analyst, this is best understood as a commercial-stage cannabinoid consumer health and distribution business rather than a traditional therapeutics developer with a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Global Sciences.